Assessment of the efficacy of omega-3 fatty acids on metabolic and inflammatory parameters in patients with schizophrenia taking clozapine and sodium valproate
Psychiatry Research Dec 17, 2017
Behdani F, et al. - In this study, the efficacy of omega-3 fatty acid (FA) on metabolic and inflammatory parameters was evaluated in patients with schizophrenia who were taking clozapine and sodium valproate. Among schizophrenic patients, omega-3 FA supplementation could improve some anthropometric indices.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
